Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth.
Posttranscriptional regulation of endothelial nitric oxide synthase (eNOS) expression is an important mechanism by which endothelial cells respond to various physiological and pathophysiological stimuli. Previously, we showed that eNOS expression was dramatically altered by the state of cell growth and that the mechanism responsible for this regulation was entirely posttranscriptional, occurring via changes in eNOS mRNA stability. The present study identifies a role for actin cytoskeleton organization in the posttranscriptional regulation of eNOS during cell growth and examines the relationship between the state of actin polymerization and eNOS expression. We identified monomeric actin (globular [G]-actin) as the major component of a 51-kDa ribonucleoprotein that binds to the eNOS mRNA 3' untranslated region in UV-crosslinking analysis. Binding activity of the ribonucleoprotein complex correlated with the relative concentration of G-actin versus filamentous actin (F-actin). ENOS transcripts colocalized with cytoplasmic G-actin in cells subjected to fluorescence in situ hybridization and G-actin fluorescence staining. In subcellular fractionation studies, eNOS transcripts were enriched in the free polysomal fraction of nonproliferating cells and enriched in the cell matrix-associated polysomal fraction of proliferating cells. Furthermore, an inverse relationship between the concentration of G-actin and eNOS expression was observed in endothelial cells subjected to pharmacological alteration of their cytoskeleton; lower G/F-actin ratios correlated with increased eNOS expression. Our findings provide some insight into how endothelial cells may use the dynamic organization of the actin cytoskeleton to regulate expression of an enzyme that is crucial to vascular homeostasis.
Searles
Charles D
CD
Division of Cardiology, Emory University, 1639 Pierce Dr, WMB 319, Atlanta, GA 30322, USA. csearle@emory.edu
Ide
Lucienne
L
Davis
Michael E
ME
Cai
Hua
H
Weber
Martina
M
D020413:3' Untranslated Regions / Q000378:metabolism; D008841:Actin Cytoskeleton / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D000199:Actins / Q000032:analysis / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D002417:Cattle; D049109:Cell Proliferation; D002478:Cells, Cultured; D047630:Depsipeptides / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000737:chemistry / Q000166:cytology / Q000201:enzymology*; D015971:Gene Expression Regulation, Enzymologic; D008387:Marine Toxins / Q000494:pharmacology; D008840:Microfilament Proteins / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000235:genetics* / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III; D020871:RNA Stability; D012333:RNA, Messenger / Q000032:analysis; D012261:Ribonucleoproteins / Q000302:isolation & purification / Q000378:metabolism
D020413:3' Untranslated Regions; D000199:Actins; D047630:Depsipeptides; D008387:Marine Toxins; D008840:Microfilament Proteins; D012333:RNA, Messenger; D012261:Ribonucleoproteins; C057531:jasplakinolide; C086235:swinholide A; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III